Baby Shampoo And Conditioner Market Size, Share & Trends Analysis Report By Type (Organic, Non-Organic), By Distribution Channel (Offline, Online), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2025 - 2030

Baby Shampoo And Conditioner Market Size, Share & Trends Analysis Report By Type (Organic, Non-Organic), By Distribution Channel (Offline, Online), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2025 - 2030


Baby Shampoo And Conditioner Market Growth & Trends

The global baby shampoo and conditioner market size is expected to reach USD 8.17 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.9% from 2025 to 2030. The market growth is attributed to rising birth rate, growing expenditure on baby care products, increasing purchasing power, and rapid urbanization. Moreover, the need to remove flakes, prevent scalp infection, and combat tangle and knots in baby’s hair is a key factor driving the market.

Increasing literacy rate and growing working women ratio are increasing the awareness among the consumers to differentiate the usage of products for baby grooming. Moreover, due to rising concerns among parents over baby’s health and hygiene, manufactures are focusing on fulfilling the need and demand of the consumers.

Working women are the prime customers for the purchase of shampoos and conditioners. Softness, suitability, anti-bacterial properties, and pleasing fragrance are the factors on which manufacturers are focusing to add more value and credibility to the product. This, in turn, influences the purchasing and spending decision of the consumers.

For instance, Johnson's Head-to-Toe baby wash and shampoo is the most popular among consumers and is currently at no.1 position in hospitals in U.S. Moreover, the brand claims that it is paraben-free, phthalate-free, no more tears formula, and is as gentle as water on the baby’s eyes.

However, presence of harmful chemicals such as phthalates and formaldehyde in shampoos is acting as a restraint to the growth of the market. Innovation, regulation standards, and marketing are the challenging issues for manufacturers while launching products in the market. Affordability, easy availability, and low awareness about presence of harmful chemicals for the baby’s skin among consumers in rural areas are boosting the growth of non-organic segment.

Consumers prefer to use an organic shampoo for their kids, making sure that babies are not exposed to any kind of dangerous chemicals. This factor is positively influencing the growth of organic shampoo and conditioners. However, manufacturers are highlighting factors such as 'gentle bath'.

Most product endorsements focus on the softness of baby skin and its incompatibility with the products used on grownups. Thus, mild shampoos have become one of the sought after products and brands including Himalaya, Natural, and Mee Mee have used it to propose some of their products. These promise to keep the baby’s hair moisturized for better and healthy growth. Inclusion of specific herbs has also been appreciated by the brands. Chamomile is one such herb that is included in baby shampoo, Centaphil. The product is expected to bring soothing effects of centaphil.

Asia Pacific held the largest share of above 56.7% in 2024. It is anticipated to emerge as the fastest growing market over the forecast period. This substantial growth and enormous share can be attributed to the birth rate in the countries including China and India. According to a report by China's National Statistical Bureau, in 2016, 17.86 million infants were born, followed by 17.23 births in the year 2017. Similarly, according to the UN report released in July 2019, India's current population is 1.37 billion and by 2050, it is expected to grow by 273 million. The data showcases a consequential birth rate.

Baby Shampoo And Conditioner Market Report Highlights
  • By type, the organic segment is expected to witness the fastest growth in the forecast period owing to its health benefits and vitamin boosted products
  • Non-organic baby shampoo and conditioner dominated the market with an 80.0% share in 2024
  • Asia Pacific held the largest market share in 2024. It is expected to witness the fastest growth over the forecast period due to growing disposable income in developing economies such as China and India, along with increasing birth rate
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Patient Type
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Acute External Ventricular Drain Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
Chapter 4. Acute External Ventricular Drain Market: Application Business Analysis
4.1. Application Market Share, 2024 & 2030
4.2. Application Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Traumatic Brain Injury
4.4.1. Traumatic Brain Injury Market, 2018 - 2030 (USD Million)
4.5. Subarachnoid Hemorrhage
4.5.1. Subarachnoid Hemorrhage Market, 2018 - 2030 (USD Million)
4.6. Intracerebral Hemorrhage
4.6.1. Intracerebral Hemorrhage Market, 2018 - 2030 (USD Million)
4.7. Other Non-traumatic Hydrocephalus Conditions
4.7.1. Other Non-traumatic Hydrocephalus Conditions Market, 2018 - 2030 (USD Million)
Chapter 5. Acute External Ventricular Drain Market: Patient Type Estimates & Trend Analysis
5.1. Patient Type Market Share, 2024 & 2030
5.2. Patient Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Patient Type, 2018 to 2030 (USD Million)
5.4. Pediatric
5.4.1. Pediatric Market, 2018 - 2030 (USD Million)
5.5. Adult
5.5.1. Adult Market, 2018 - 2030 (USD Million)
Chapter 6. Acute External Ventricular Drain Market: Regional Estimates & Trend Analysis by Application and Patient Type
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key country dynamic
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. U.S. Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key country dynamic
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. Canada Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key country dynamic
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. Mexico Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamic
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. UK Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamic
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. Germany Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamic
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. France Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamic
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. Italy Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamic
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Spain Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. China
6.6.2.1. Key country dynamic
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. China Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Japan
6.6.3.1. Key country dynamic
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. Japan Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key country dynamic
6.6.4.2. Regulatory framework
6.6.4.3. Competitive insights
6.6.4.4. India Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key country dynamic
6.6.5.2. Regulatory framework
6.6.5.3. Competitive insights
6.6.5.4. South Korea Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key country dynamic
6.6.6.2. Regulatory framework
6.6.6.3. Competitive insights
6.6.6.4. Australia Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key country dynamic
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. Brazil Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key country dynamic
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Argentina Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.4. Colombia
6.7.4.1. Key country dynamic
6.7.4.2. Regulatory framework
6.7.4.3. Competitive insights
6.7.4.4. Colombia Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.5. Argentina
6.7.5.1. Key country dynamic
6.7.5.2. Regulatory framework
6.7.5.3. Competitive insights
6.7.5.4. Argentina Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key country dynamic
6.8.2.2. Regulatory framework
6.8.2.3. Competitive insights
6.8.2.4. Saudi Arabia Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. UAE
6.8.3.1. Key country dynamic
6.8.3.2. Regulatory framework
6.8.3.3. Competitive insights
6.8.3.4. UAE Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4. South Africa
6.8.4.1. Key country dynamic
6.8.4.2. Regulatory framework
6.8.4.3. Competitive insights
6.8.4.4. South Africa Acute External Ventricular Drain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Medtronic
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Integra LifeSciences
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Natus
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Fuji Systems
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Spiegelberg GmbH & Co. KG
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Sophysa
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Neuromedex GmbH
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings